New NIH grants announced

The New Year is already looking pretty rosy over at the National Institutes of Health. On December 28th the agency announced a new round of grants made possible through last year's NIH stimulus boost. The $80 million program, dubbed the NIH Director's Opportunity for Research in Five Thematic Areas, will fund research projects in a handful of areas - genomics and other high throughput technologies, translational science, enabling health care reform, global health, and "Reinvigorating the Biomed

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The New Year is already looking pretty rosy over at the National Institutes of Health. On December 28th the agency announced a new round of grants made possible through last year's NIH stimulus boost. The $80 million program, dubbed the NIH Director's Opportunity for Research in Five Thematic Areas, will fund research projects in a handful of areas - genomics and other high throughput technologies, translational science, enabling health care reform, global health, and "Reinvigorating the Biomedical Research Community." Awards will top out at $1.5 million over three years, and projects should emphasize (true to the intent of the stimulus legislation) "high short-term impact, and a high likelihood of enabling growth and investment in biomedical research and development, public health, and health care delivery," according to the NIH. The deadline for submitting applications is March 15. You can get the details straight from the horse's mouth linkurl:here;http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-005.html and a summary of the program linkurl:here.;http://writedit.wordpress.com/2010/01/03/more-arra-largesse/
**__Related stories:__***linkurl:NIH's New Year's resolution?;http://www.the-scientist.com/blog/display/56229/
[22nd December 2009]*linkurl:A windfall year at NIH;http://www.the-scientist.com/blog/display/56220/
[16th December 2009]*linkurl:New NIH forms raise concerns;http://www.the-scientist.com/blog/display/56209/
[8th December 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies